Department of Radiology, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Department of Radiology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Br J Cancer. 2021 Jul;125(1):15-22. doi: 10.1038/s41416-021-01333-w. Epub 2021 Mar 26.
Retrospective studies have shown artificial intelligence (AI) algorithms can match as well as enhance radiologist's performance in breast screening. These tools can facilitate tasks not feasible by humans such as the automatic triage of patients and prediction of treatment outcomes. Breast imaging faces growing pressure with the exponential growth in imaging requests and a predicted reduced workforce to provide reports. Solutions to alleviate these pressures are being sought with an increasing interest in the adoption of AI to improve workflow efficiency as well as patient outcomes. Vast quantities of data are needed to test and monitor AI algorithms before and after their incorporation into healthcare systems. Availability of data is currently limited, although strategies are being devised to harness the data that already exists within healthcare institutions. Challenges that underpin the realisation of AI into everyday breast imaging cannot be underestimated and the provision of guidance from national agencies to tackle these challenges, taking into account views from a societal, industrial and healthcare prospective is essential. This review provides background on the evaluation and use of AI in breast imaging in addition to exploring key ethical, technical, legal and regulatory challenges that have been identified so far.
回顾性研究表明,人工智能 (AI) 算法可以与放射科医生的表现相匹配,甚至可以提高其表现,尤其是在乳腺癌筛查方面。这些工具可以帮助人类完成一些难以完成的任务,例如自动分诊患者和预测治疗效果。随着成像请求的指数级增长和预计提供报告的工作人员减少,乳腺成像面临越来越大的压力。为了缓解这些压力,人们越来越关注采用人工智能来提高工作流程效率和改善患者结果。在将人工智能算法纳入医疗保健系统之前和之后,需要大量的数据进行测试和监测。尽管正在制定策略来利用医疗机构中现有的数据,但数据的可用性仍然有限。为了将人工智能应用于日常的乳腺成像,必须认真应对其实现所面临的挑战,同时还需要考虑来自社会、工业和医疗保健等多方面的意见。本文对人工智能在乳腺成像中的评估和应用进行了综述,同时还探讨了迄今为止已确定的关键伦理、技术、法律和监管挑战。